BNP PARIBAS ARBITRAGE/PUT/PFIZER INC/28/0.1/21.06.24 Stock

Warrant

EC3MB

NLBNPFR1W721

Real-time Euronext Paris 04:08:45 2024-05-29 EDT
0.05 EUR -9.09% Intraday chart for BNP PARIBAS ARBITRAGE/PUT/PFIZER INC/28/0.1/21.06.24
Current month-80.00%
1 month-81.36%
Date Price Change
24-05-29 0.05 -9.09%
24-05-28 0.055 +120.00%
24-05-27 0.025 -44.44%
24-05-24 0.045 +28.57%
24-05-23 0.035 +40.00%

Real-time Euronext Paris

Last update May 29, 2024 at 04:08 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
EC3MB
ISINNLBNPFR1W721
Date issued 2023-11-22
Strike 28 $
Maturity 2024-06-21 (24 Days)
Parity 10 : 1
Emission price 0.13
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.335
Lowest since issue 0.02
Spread 0.02
Spread %33.33%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.3 USD
Average target price
31.92 USD
Spread / Average Target
+12.78%
Consensus
  1. Stock Market
  2. Warrants
  3. EC3MB Warrant